SCHEMBL484743

SCHEMBL484743

O=C(NC1CCc2ccc(C(=O)N3CCC4(CC3)CCN(C(=O)c3ccc(F)cc3F)CC4)cc21)c1ccccc1Cl

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.43
HSD11B1 P28845 3/20 0.43
TAS1R3 Q7RTX0 3/20 0.42
TAS1R1 Q7RTX1 3/20 0.42
TAS1R2 Q8TE23 2/20 0.42
MAPK1 P28482 2/20 0.40
SPTLC2 O15270 1/20 0.40
PDE10A Q9Y233 1/20 0.39
USP2 O75604 2/20 0.39
CYP1A2 P05177 2/20 0.39
CYP3A4 P08684 2/20 0.39
CYP2D6 P10635 1/20 0.39
MGLL Q99685 1/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
HTR1A P08908 2/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
UBE2M P61081 1/20 0.38
DCUN1D1 Q96GG9 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL484382 0.96 ALDH1A1 (0.42) ALDH1A1HSD11B1TAS1R3TAS1R1TAS1R2
SCHEMBL484640 0.94 HSD11B1 (0.47) ALDH1A1HSD11B1TAS1R3TAS1R1TAS1R2
SCHEMBL484737 0.91 HSD11B1 (0.45) ALDH1A1HSD11B1TAS1R3TAS1R1TAS1R2
SCHEMBL484789 0.90 CYP3A4 (0.43) ALDH1A1TAS1R3TAS1R1TAS1R2MAPK1
SCHEMBL484970 0.89 ALDH1A1 (0.40) ALDH1A1HSD11B1TAS1R3TAS1R1TAS1R2
SCHEMBL484943 0.89 CYP2D6 (0.45) ALDH1A1HSD11B1TAS1R3TAS1R1TAS1R2
SCHEMBL2816807 0.89 CYP3A4 (0.46) ALDH1A1HSD11B1TAS1R3TAS1R1TAS1R2
SCHEMBL485310 0.88 CYP2D6 (0.46) ALDH1A1TAS1R3TAS1R1TAS1R2MAPK1
SCHEMBL484240 0.87 ALDH1A1 (0.42) ALDH1A1HSD11B1TAS1R3TAS1R1TAS1R2
SCHEMBL484773 0.87 CYP2D6 (0.45) ALDH1A1HSD11B1TAS1R3TAS1R1TAS1R2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130231327-A1 Substituted Spiro-Amide Compounds GRUENENTHAL GMBH (DE) 2013-09-05 US claimed
US-8455475-B2 Substituted spiro-amide compounds GRUENENTHAL GMBH (DE) 2013-06-04 US claimed
EP-2411381-A1 SUBSTITUTED SPIRO-AMIDE COMPOUNDS Grünenthal GmbH (DE) 2012-02-01 EP claimed
US-20100249095-A1 Substituted Spiro-amide Compounds GRUENENTHAL GMBH (DE) 2010-09-30 US claimed
WO-2010108651-A1 SUBSTITUTED SPIRO-AMIDE COMPOUNDS Grünenthal GmbH (DE) 2010-09-30 WO claimed
US-20130231327-A1 Substituted Spiro-Amide Compounds GRUENENTHAL GMBH (DE) 2013-09-05 US disclosed
US-8455475-B2 Substituted spiro-amide compounds GRUENENTHAL GMBH (DE) 2013-06-04 US disclosed
EP-2411381-A1 SUBSTITUTED SPIRO-AMIDE COMPOUNDS Grünenthal GmbH (DE) 2012-02-01 EP disclosed
US-20100249095-A1 Substituted Spiro-amide Compounds GRUENENTHAL GMBH (DE) 2010-09-30 US disclosed
WO-2010108651-A1 SUBSTITUTED SPIRO-AMIDE COMPOUNDS Grünenthal GmbH (DE) 2010-09-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130231327-A1 Substituted Spiro-Amide Compounds BDKRB1, BDKRB2, REN ALDH1A1 2086/4885HSD11B1 1789/4885TAS1R3 339/4885
US-20100249095-A1 Substituted Spiro-amide Compounds BDKRB1, BDKRB2, REN ALDH1A1 2086/4885HSD11B1 1789/4885TAS1R3 339/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.